Biomatlante | Bone graft substitutes & implantable medical devices

- Editorial
- Since the establishment in 1995, BIOMATLANTE excels in the worldwide market of synthetic bone substitutes.
  
  Positioned among the leaders of this market segment, we develop, manufacture and commercialize our products under our own label, under private labels or OEM. Our product line is used as much in the orthopaedic and trauma surgery as it is used in spine, ENT, stomatology and dental surgery.
  
  Chantal Gobin
  President.
- - Subscribing to RSS feeds
  - Requests for information
  Newsletter Inscription
  E-mail *

- Biomatlante - Bone grafts substitutes
- Inspection classified as N.A.I
  A level 2 baseline QSIT inspection was conducted at BIOMATLANTE from January the 26th to January the 29th, by an investigator from the New England District Office.
  » read more
- Inspection classified as N.A.I
  A level 2 baseline QSIT inspection was conducted at BIOMATLANTE from January the 26th to January the 29th, by an investigator from the New England District Office.
  » read more
- - H2bOne
    H2bOne is comprised of micro and nano-granules of biphasic calcium phosphate and is presented in the form of a malleable, injectable paste for use in the filling of bone losses and or in increases in the maxillary area.
    » read more

- Copyright (cc) 2010 Biomatlante | Site map | Credits | Legal | Contact